Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

798639

registered interest
date	01/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the SelectMDx urine test for prostate cancer will be made available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	117033
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The future availability of any new or novel tests on the National Health Service, such as the SelectMDx test for prostate cancer, would be subject to large scale clinical trials demonstrating the safety and efficacy of the diagnostic approach and subsequent assessments of its cost effectiveness for routine use.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:47:34 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

759368

registered interest
date	11/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that men are able to access early prostate tests.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10002
answer	answer is ministerial correction date of answer 18/09/2017 answer text <p>The National Health Service Prostate Cancer Risk Management Programme (PCRMP) provides general practitioners and primary care professionals with information to counsel men who ask about prostate cancer and/or prostate-specific antigen (PSA) testing. Men over 50 who decide to have a PSA test based on this information can do so for free on the NHS.</p><p>The PCRMP information pack was revised and updated in March 2016 and is available at the following link:</p><p><a href="http://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview" target="_blank">www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview</a></p><p>The PCRMP has also produced information leaflets that healthcare professionals can use when discussing the test with eligible men, which are available at the following link.</p><p><a href="http://www.gov.uk/government/collections/prostate-cancer-risk-management-programme-supporting-documents" target="_blank">www.gov.uk/government/collections/prostate-cancer-risk-management-programme-supporting-documents</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/09/2017 13:33:03 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

425129

registered interest
date	30/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of an annual screening programme on early detection of prostate cancer.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	14176
answer	answer is ministerial correction date of answer 16/11/2015 answer text <p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. In 2010, the UK NSC recommended against a screening programme for prostate cancer as there was no clear evidence that the benefit to screen for prostate cancer outweighed the harms. The UK NSC re-affirmed this decision in 2012 and is in the process of reviewing this policy currently.</p><br /><p>The School of Health and Related Research at the University of Sheffield performed an option appraisal for the UK NSC based on the latest trial evidence for screening for prostate cancer in 2013. A number of screening strategies were considered including annual screening in men aged 50 to 74 years. The overall survival benefit with all strategies was small and outweighed by the harms of over diagnosis and the adverse effects of over treatment.</p><br /><p>Public Health England (PHE) ran a local pilot campaign for six weeks in 2014, specifically targeting prostate cancer within Black African-Caribbean men, because of their significantly increased risk of developing prostate cancer. The campaign ran in six London boroughs. In addition, PHE will be running a national campaign on “Blood in Pee” in early 2016. This is primarily aimed at bladder and kidney cancer but blood in the urine can also be a sign of prostate cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 14175 14177 14178 question first answered 16/11/2015 17:46:18 answering member 3918 label Biography information for Jane Ellison
tabling member	3910 label Biography information for Guto Bebb

420111

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress has been made on implementation of a national screening programme for prostate cancer.
tabling member constituency	Blaydon
tabling member printed	Mr David Anderson
uin	11063
answer	answer is ministerial correction date of answer 19/10/2015 answer text <br /><p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy.</p><br /><p>The UK NSC re-affirmed in March 2012 that a national screening programme for prostate cancer should not be offered. This is because:</p><br /><p>- The test for prostate cancer, the prostate specific antigen test, is not effective enough and does not identify a large proportion of men who in fact have prostate cancer;</p><p>- A positive test will lead in most cases to a biopsy, which often does not give a definitive answer and leads to anxiety and to further investigations; and</p><p>- Current research indicates for every 100,000 men at age 50 offered screening, 748 would end up being treated. The men accepting screening would have their lives extended on average by a day – while 274 men would be made impotent, 25 incontinent and 17 would have rectal problems as a result of the treatment.</p><p><strong></strong></p><p>The UK NSC is currently reviewing its recommendation on whether a national screening programme for prostate cancer should be offered. Ministers expect to receive a recommendation shortly.</p><p><strong></strong></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/10/2015 13:12:06 answering member 3918 label Biography information for Jane Ellison
tabling member	1486 label Biography information for Mr David Anderson